Ambev Price Target Maintained With a $3.30/Share by B of A Securities

Ratings actions from Benzinga: (END) Dow Jones Newswires October 07, 2026 08:25 ET (12:25 GMT) The statements in this document shall not be considered as an objective or independent explanation of the matters. Please note that this document (a) has not been prepared in accordance with legal requirements designed to promote the independence of investment research, and (b) is not subject to any prohibition on dealing ahead of the dissemination or publication of investment research.